Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson’s disease
Frontiers in Pharmacology · 10.05.2023 · 14
DOI: 10.3389/fphar.2023.1117337 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 10.05.2023. Verfasst von Ting He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thyroid Surgery, Department of General Surgery and Laboratory of Thyroid and Parathyroid Disease, Frontiers Science Center for Disease-re…. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Parkinson’s disease (PD), the second most common neurodegenerative disease worldwide, often occurs in middle-aged and elderly individuals. The pathogenesis of PD is complex and includes mitochondrial dysfunction, and oxidative stress. Recently, natural products with multiple structures and their bioactive components have become one of the most important resources for small molecule PD drug research targeting mitochondrial dysfunction. Multiple lines of studies have proven that natural products display ameliorative benefits in PD treatment by regulating mitochondrial dysfunction. Therefore, a comprehensive search of recent published articles between 2012 and 2022 in PubMed, Web of Science, Elesvier, Wliey and Springer was carried out, focusing on original publications related to natural products against PD by restoring mitochondrial dysfunction. This paper presented the mechanisms of various kinds of natural products on PD-related mitochondrial dysfunction regulation and provided evidence that natural products are promising to be developed as drugs for PD therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Thyroid Surgery, Department of General Surgery and Laboratory of Thyroid and Parathyroid Disease, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chen…
Zitieren
APA
He, T., Lin, X., Su, A., Zhang, Y., Xing, Z., Mi, L., Wei, T., Li, Z., & Wu, W. (2023). Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson’s disease. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1117337
Vancouver
He T, Lin X, Su A, Zhang Y, Xing Z, Mi L, et al. Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson’s disease. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1117337
BibTeX
@article{He2023,
author = {He, Ting and Lin, Xiaoyan and Su, Anping and Zhang, Yujie and Xing, Zhichao and Mi, Li and Wei, Tao and Li, Zhihui and Wu, Wenshuang},
title = {Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson’s disease},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1117337}
}
EUVIMED